5-hydroxydecanoate has been researched along with Disease Models, Animal in 35 studies
5-hydroxydecanoic acid: Potassium Channel Blocker; RN refers to parent cpd
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To ascertain if levosimendan postconditioning can alleviate lung ischemia-reperfusion injury (LIRI) in rats." | 7.81 | Influence of levosimendan postconditioning on apoptosis of rat lung cells in a model of ischemia-reperfusion injury. ( Ge, S; Guo, Z; Liu, H; Shi, Y; Zhang, C, 2015) |
| " The present study examined whether or not cilostazol reduces the myocardial infarct size, and investigated its mechanism in a rabbit model of myocardial infarction." | 7.77 | Cilostazol protects the heart against ischaemia reperfusion injury in a rabbit model of myocardial infarction: focus on adenosine, nitric oxide and mitochondrial ATP-sensitive potassium channels. ( Aoyama, T; Bai, Y; Iwasa, M; Minatoguchi, S; Murakami, H; Nishigaki, K; Sumi, S; Takemura, G; Uno, B; Ushikoshi, H; Yamada, Y, 2011) |
| "The insulin-sensitizing drug pioglitazone has been reported to be protective against myocardial infarction." | 7.75 | Antidiabetic drug pioglitazone protects the heart via activation of PPAR-gamma receptors, PI3-kinase, Akt, and eNOS pathway in a rabbit model of myocardial infarction. ( Fujiwara, H; Fujiwara, T; Iwasa, M; Kawamura, I; Kobayashi, H; Minatoguchi, S; Nagashima, K; Narentuoya, B; Nishigaki, K; Sumi, S; Takemura, G; Ushikoshi, H; Yamaki, T; Yasuda, S, 2009) |
| "To ascertain if levosimendan postconditioning can alleviate lung ischemia-reperfusion injury (LIRI) in rats." | 3.81 | Influence of levosimendan postconditioning on apoptosis of rat lung cells in a model of ischemia-reperfusion injury. ( Ge, S; Guo, Z; Liu, H; Shi, Y; Zhang, C, 2015) |
| " The present study examined whether or not cilostazol reduces the myocardial infarct size, and investigated its mechanism in a rabbit model of myocardial infarction." | 3.77 | Cilostazol protects the heart against ischaemia reperfusion injury in a rabbit model of myocardial infarction: focus on adenosine, nitric oxide and mitochondrial ATP-sensitive potassium channels. ( Aoyama, T; Bai, Y; Iwasa, M; Minatoguchi, S; Murakami, H; Nishigaki, K; Sumi, S; Takemura, G; Uno, B; Ushikoshi, H; Yamada, Y, 2011) |
| "The insulin-sensitizing drug pioglitazone has been reported to be protective against myocardial infarction." | 3.75 | Antidiabetic drug pioglitazone protects the heart via activation of PPAR-gamma receptors, PI3-kinase, Akt, and eNOS pathway in a rabbit model of myocardial infarction. ( Fujiwara, H; Fujiwara, T; Iwasa, M; Kawamura, I; Kobayashi, H; Minatoguchi, S; Nagashima, K; Narentuoya, B; Nishigaki, K; Sumi, S; Takemura, G; Ushikoshi, H; Yamaki, T; Yasuda, S, 2009) |
| " In the present study, we investigated the effects of administration of non-hypotensive doses of ATP-sensitive K(+) channel (K(ATP)) openers (nicorandil and cromakalim), a specific mitochondrial K(ATP) channel blocker (5-hydroxydecanoate (5-HD)) and a specific sarcolemmal K(ATP) channel blocker (HMR 1883; (1-[5-[2-(5-chloro-o-anisamido)ethyl]-2-methoxyphenyl]sulfonyl-3-methylthiourea) prior to and during coronary occlusion as well as prior to and during post-ischemic reperfusion on survival rate, ischemia-induced and reperfusion-induced arrhythmias and myocardial infarct size in anesthetized albino rabbits." | 3.72 | Mitochondrial K ATP channel activation is important in the antiarrhythmic and cardioprotective effects of non-hypotensive doses of nicorandil and cromakalim during ischemia/reperfusion: a study in an intact anesthetized rabbit model. ( Das, B; Sarkar, C, 2003) |
| " This study was designed to determine whether clofilium exhibits antifibrillatory activity in a pinacidil + hypoxia-induced model of ventricular fibrillation (VF) in Langendorff-perfused hearts." | 3.69 | Antifibrillatory effects of clofilium in the rabbit isolated heart. ( Chi, L; Friedrichs, GS; Green, AL; Lucchesi, BR, 1994) |
| "The duration of ventricular tachycardia (VT) + VF, the number of VT + VF episodes and the severity of arrhythmias were all significantly reduced by Ex-4 compared to those in myocardial ischemia group (p < 0." | 1.39 | Exendin-4 attenuates ischemia-induced ventricular arrhythmias in rats. ( Daoqun, J; Jie, G; Kai, Z; Lin, Z; Yongbo, W; Zhiqiang, C, 2013) |
| "Pretreatment with diazoxide significantly reduced infarct volume and brain edema formation after ASDH." | 1.39 | The neuroprotective effect of diazoxide is mediated by mitochondrial ATP-dependent potassium channels in a rat model of acute subdural hematoma. ( Nakagawa, I; Nakase, H; Nishimura, F; Park, YS; Tamura, K; Wajima, D, 2013) |
| "Sevoflurane treatment also caused increased phosphorylation of p38 MAPK at 24 and 72 h after reperfusion." | 1.38 | Delayed neuroprotection induced by sevoflurane via opening mitochondrial ATP-sensitive potassium channels and p38 MAPK phosphorylation. ( Guo, Q; Wang, E; Wang, N; Xia, P; Ye, Z; Yuan, Y, 2012) |
| "Nicorandil was effective to preserve ejection fraction after brain death, and myocardial mitochondrial adenosine triphosphate-sensitive potassium channels may be involved in this action." | 1.37 | Nicorandil preserves myocardial function following brain death in rats by mitochondrial adenosine triphosphate-sensitive potassium channel-dependent mechanism. ( Hayashi, Y; Iwasaki, M; Kamibayashi, T; Mashimo, T; Yamanaka, H, 2011) |
| "Treatment with sulforaphane inhibited an increase in the post-ischemic left ventricular end-diastolic pressure (LVEDP) and improved the post-ischemic left ventricular developed pressure (LVDP), +/-dP/dt, and coronary flow as compared with the untreated control hearts." | 1.36 | Sulforaphane protects ischemic injury of hearts through antioxidant pathway and mitochondrial K(ATP) channels. ( Chae, HJ; Chae, SW; Gao, S; Kim, DS; Kim, SH; Lee, GH; Park, BH; Piao, CS, 2010) |
| " Studies also found that iptakalim and diazoxide could reduce the enzymic activities and mRNA levels of inducible nitric oxide synthase elicited by chronic administration of rotenone." | 1.33 | Activation of mitochondrial ATP-sensitive potassium channels improves rotenone-related motor and neurochemical alterations in rats. ( Ding, JH; Hu, G; Liu, SY; Liu, X; Long, Y; Sun, YH; Wang, F; Wang, H; Wu, J; Yang, Y; Yao, HH, 2006) |
| "Pretreatment with diazoxide significantly reduced the infarct volume from 6." | 1.33 | MitoKATP-channel opener protects against neuronal death in rat venous ischemia. ( Alessandri, B; Heimann, A; Kempski, O; Nakagawa, I, 2005) |
| "Myocardial infarction was induced by 30-min coronary occlusion/2-h reperfusion in rat hearts in situ, and infarct size was expressed as a percentage of the area at risk (% IS/AR)." | 1.32 | Mitochondrial KATP channel-dependent and -independent phases of ischemic preconditioning against myocardial infarction in the rat. ( Miki, T; Miura, T; Nozawa, Y; Ohnuma, Y; Shimamoto, K; Yano, T, 2003) |
| "Cardiac hypertrophy has been demonstrated to decreases the ATP-sensitive potassium channels (K(ATP)), the major protective mechanism following the energy depletion, a common condition seen during the reperfusion after open heart surgery." | 1.32 | Ischemic preconditioning prevents reperfusion heart injury in cardiac hypertrophy by activation of mitochondrial KATP channels. ( Maeda, H; Rajesh, KG; Sasaguri, S; Suzuki, R; Xing, Y, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (11.43) | 18.2507 |
| 2000's | 21 (60.00) | 29.6817 |
| 2010's | 9 (25.71) | 24.3611 |
| 2020's | 1 (2.86) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Kai, Z | 1 |
| Yongbo, W | 1 |
| Lin, Z | 1 |
| Jie, G | 1 |
| Daoqun, J | 1 |
| Zhiqiang, C | 1 |
| Zhang, C | 1 |
| Guo, Z | 1 |
| Liu, H | 1 |
| Shi, Y | 1 |
| Ge, S | 1 |
| Baharvand, B | 1 |
| Dehaj, ME | 1 |
| Rasoulian, B | 1 |
| Namdari, M | 1 |
| Shikhani, Y | 1 |
| Kiani, AA | 1 |
| Sivarajah, A | 1 |
| Collino, M | 1 |
| Yasin, M | 1 |
| Benetti, E | 1 |
| Gallicchio, M | 1 |
| Mazzon, E | 1 |
| Cuzzocrea, S | 1 |
| Fantozzi, R | 1 |
| Thiemermann, C | 2 |
| Yang, YJ | 1 |
| Zhang, S | 2 |
| Ding, JH | 2 |
| Zhou, F | 1 |
| Hu, G | 2 |
| Ye, Y | 1 |
| Lin, Y | 1 |
| Perez-Polo, JR | 1 |
| Birnbaum, Y | 1 |
| Yasuda, S | 1 |
| Kobayashi, H | 1 |
| Iwasa, M | 2 |
| Kawamura, I | 1 |
| Sumi, S | 2 |
| Narentuoya, B | 1 |
| Yamaki, T | 1 |
| Ushikoshi, H | 2 |
| Nishigaki, K | 2 |
| Nagashima, K | 1 |
| Takemura, G | 3 |
| Fujiwara, T | 2 |
| Fujiwara, H | 2 |
| Minatoguchi, S | 3 |
| Piao, CS | 1 |
| Gao, S | 1 |
| Lee, GH | 1 |
| Kim, DS | 1 |
| Park, BH | 1 |
| Chae, SW | 1 |
| Chae, HJ | 1 |
| Kim, SH | 1 |
| Quindry, JC | 1 |
| Schreiber, L | 1 |
| Hosick, P | 1 |
| Wrieden, J | 1 |
| Irwin, JM | 1 |
| Hoyt, E | 1 |
| Iwasaki, M | 1 |
| Hayashi, Y | 1 |
| Yamanaka, H | 1 |
| Kamibayashi, T | 1 |
| Mashimo, T | 1 |
| Nuñez, IP | 1 |
| Fantinelli, J | 1 |
| Arbeláez, LF | 1 |
| Mosca, SM | 1 |
| Bai, Y | 1 |
| Murakami, H | 1 |
| Yamada, Y | 1 |
| Aoyama, T | 1 |
| Uno, B | 1 |
| Ye, Z | 1 |
| Guo, Q | 1 |
| Wang, N | 2 |
| Xia, P | 1 |
| Yuan, Y | 1 |
| Wang, E | 1 |
| Nakagawa, I | 2 |
| Wajima, D | 1 |
| Tamura, K | 1 |
| Nishimura, F | 1 |
| Park, YS | 1 |
| Nakase, H | 1 |
| Shimizu, Y | 1 |
| Hashimoto, K | 1 |
| Uno, Y | 1 |
| Arai, M | 1 |
| Chen, X | 1 |
| Lu, C | 2 |
| Shimomura, M | 1 |
| Nozawa, Y | 1 |
| Miura, T | 1 |
| Miki, T | 1 |
| Ohnuma, Y | 1 |
| Yano, T | 1 |
| Shimamoto, K | 1 |
| Iliodromitis, EK | 1 |
| Cokkinos, P | 1 |
| Zoga, A | 1 |
| Steliou, I | 1 |
| Vrettou, AR | 1 |
| Kremastinos, DT | 1 |
| Das, B | 1 |
| Sarkar, C | 1 |
| Maslov, LN | 1 |
| Lishmanov, YB | 1 |
| Solenkova, NV | 1 |
| Gross, GJ | 2 |
| Stefano, GB | 1 |
| Tam, SW | 1 |
| Clark, JE | 1 |
| Naughton, P | 1 |
| Shurey, S | 1 |
| Green, CJ | 1 |
| Johnson, TR | 1 |
| Mann, BE | 1 |
| Foresti, R | 1 |
| Motterlini, R | 1 |
| Liu, D | 1 |
| Slevin, JR | 1 |
| Chan, SL | 1 |
| Hansson, M | 1 |
| Elmér, E | 1 |
| Mattson, MP | 1 |
| Rajesh, KG | 1 |
| Sasaguri, S | 1 |
| Suzuki, R | 1 |
| Xing, Y | 1 |
| Maeda, H | 1 |
| Yang, Y | 1 |
| Liu, X | 1 |
| Long, Y | 1 |
| Wang, F | 1 |
| Liu, SY | 1 |
| Sun, YH | 1 |
| Yao, HH | 1 |
| Wang, H | 1 |
| Wu, J | 1 |
| Alessandri, B | 1 |
| Heimann, A | 1 |
| Kempski, O | 1 |
| Xu, D | 1 |
| Li, Y | 1 |
| Wang, J | 1 |
| Davey, AK | 1 |
| Evans, AM | 1 |
| Mayanagi, K | 1 |
| Gáspár, T | 1 |
| Katakam, PV | 1 |
| Busija, DW | 1 |
| Colantuono, G | 1 |
| Tiravanti, EA | 1 |
| Di Venosa, N | 1 |
| Cazzato, A | 1 |
| Rastaldo, R | 1 |
| Cagiano, R | 1 |
| D'Agostino, D | 1 |
| Federici, A | 1 |
| Fiore, T | 1 |
| Lucchinetti, E | 1 |
| Jamnicki, M | 1 |
| Fischer, G | 1 |
| Zaugg, M | 1 |
| Kaneda, K | 1 |
| Miyamae, M | 1 |
| Sugioka, S | 1 |
| Okusa, C | 1 |
| Inamura, Y | 1 |
| Domae, N | 1 |
| Kotani, J | 1 |
| Figueredo, VM | 1 |
| Lee, SH | 1 |
| Yang, MK | 1 |
| Lim, JH | 1 |
| Seo, HW | 1 |
| Yi, KY | 1 |
| Yoo, SE | 1 |
| Lee, BH | 1 |
| Won, HS | 1 |
| Lee, CS | 1 |
| Choi, WS | 1 |
| Shin, HS | 1 |
| Friedrichs, GS | 1 |
| Chi, L | 1 |
| Green, AL | 1 |
| Lucchesi, BR | 1 |
| Moritani, K | 1 |
| Miyazaki, T | 1 |
| Miyoshi, S | 1 |
| Asanagi, M | 1 |
| Zhao, LS | 1 |
| Mitamura, H | 1 |
| Ogawa, S | 1 |
| Yao, Z | 1 |
| Hide, EJ | 1 |
| Piper, J | 1 |
35 other studies available for 5-hydroxydecanoate and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Exendin-4 attenuates ischemia-induced ventricular arrhythmias in rats.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Decanoic Acids; Disease Models, Animal; Exenatide; | 2013 |
Influence of levosimendan postconditioning on apoptosis of rat lung cells in a model of ischemia-reperfusion injury.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Cardiotonic Agents; Caspase 3; Decanoic Acids; Disea | 2015 |
Delayed anti-arrhythmic effect of nitroglycerin in anesthetized rats: involvement of CGRP, PKC and mK ATP channels.
Topics: Anesthesia; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzophenanthridines; Calcitonin | 2009 |
Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R.
Topics: Active Transport, Cell Nucleus; Animals; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Stero | 2009 |
Iptakalim protects against MPP+-induced degeneration of dopaminergic neurons in association with astrocyte activation.
Topics: 1-Methyl-4-phenylpyridinium; Analysis of Variance; Animals; Animals, Newborn; Astrocytes; Brain Stem | 2009 |
Oral glyburide, but not glimepiride, blocks the infarct-size limiting effects of pioglitazone.
Topics: Administration, Oral; Animals; Body Weight; Coronary Vessels; Data Interpretation, Statistical; Deca | 2008 |
Antidiabetic drug pioglitazone protects the heart via activation of PPAR-gamma receptors, PI3-kinase, Akt, and eNOS pathway in a rabbit model of myocardial infarction.
Topics: Androstadienes; Anilides; Animals; Blood Glucose; Blotting, Western; Decanoic Acids; Disease Models, | 2009 |
Sulforaphane protects ischemic injury of hearts through antioxidant pathway and mitochondrial K(ATP) channels.
Topics: Animals; Antioxidants; Atrial Natriuretic Factor; bcl-2-Associated X Protein; Caspase 3; Decanoic Ac | 2010 |
Mitochondrial KATP channel inhibition blunts arrhythmia protection in ischemic exercised hearts.
Topics: Animals; Arrhythmias, Cardiac; Benzamides; Catalase; Decanoic Acids; Disease Models, Animal; Electro | 2010 |
Nicorandil preserves myocardial function following brain death in rats by mitochondrial adenosine triphosphate-sensitive potassium channel-dependent mechanism.
Topics: Animals; Blood Pressure; Brain Death; Cardiac Output; Cardiotonic Agents; Decanoic Acids; Disease Mo | 2011 |
Mitochondrial KATP channels participate in the limitation of infarct size by cariporide.
Topics: Animals; Calcium; Cardiotonic Agents; Decanoic Acids; Diazoxide; Disease Models, Animal; Guanidines; | 2011 |
Cilostazol protects the heart against ischaemia reperfusion injury in a rabbit model of myocardial infarction: focus on adenosine, nitric oxide and mitochondrial ATP-sensitive potassium channels.
Topics: Adenosine; Animals; Cardiotonic Agents; Cilostazol; Decanoic Acids; Disease Models, Animal; Drug Eva | 2011 |
Delayed neuroprotection induced by sevoflurane via opening mitochondrial ATP-sensitive potassium channels and p38 MAPK phosphorylation.
Topics: Analysis of Variance; Animals; Anti-Arrhythmia Agents; Brain Infarction; Cell Count; Decanoic Acids; | 2012 |
The neuroprotective effect of diazoxide is mediated by mitochondrial ATP-dependent potassium channels in a rat model of acute subdural hematoma.
Topics: Animals; Brain Infarction; Decanoic Acids; Diazoxide; Disease Models, Animal; Hematoma, Subdural, Ac | 2013 |
The role of serotonin in ischemic cellular damage and the infarct size-reducing effect of sarpogrelate, a 5-hydroxytryptamine-2 receptor blocker, in rabbit hearts.
Topics: Adenosine Triphosphate; Alkaloids; Animals; Benzophenanthridines; Decanoic Acids; Disease Models, An | 2002 |
Mitochondrial KATP channel-dependent and -independent phases of ischemic preconditioning against myocardial infarction in the rat.
Topics: Adenosine Triphosphate; Animals; Decanoic Acids; Disease Models, Animal; Hemodynamics; Hydroxy Acids | 2003 |
Oral nicorandil recaptures the waned protection from preconditioning in vivo.
Topics: Administration, Oral; Animals; Blood Pressure; Decanoic Acids; Disease Models, Animal; Drug Combinat | 2003 |
Mitochondrial K ATP channel activation is important in the antiarrhythmic and cardioprotective effects of non-hypotensive doses of nicorandil and cromakalim during ischemia/reperfusion: a study in an intact anesthetized rabbit model.
Topics: Analysis of Variance; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac | 2003 |
Activation of peripheral delta opioid receptors eliminates cardiac electrical instability in a rat model of post-infarction cardiosclerosis via mitochondrial ATP-dependent K+ channels.
Topics: Adenosine Triphosphate; Analgesics, Opioid; Animals; Decanoic Acids; Disease Models, Animal; Drug An | 2003 |
Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule.
Topics: Animals; Carbon Monoxide; Cardiotonic Agents; Cells, Cultured; Decanoic Acids; Disease Models, Anima | 2003 |
Involvement of mitochondrial K+ release and cellular efflux in ischemic and apoptotic neuronal death.
Topics: Animals; Apoptosis; Brain Ischemia; Cell Death; Cell Hypoxia; Cells, Cultured; Cyanides; Decanoic Ac | 2003 |
Ischemic preconditioning prevents reperfusion heart injury in cardiac hypertrophy by activation of mitochondrial KATP channels.
Topics: Adenosine Triphosphate; Animals; Cardiomegaly; Decanoic Acids; Disease Models, Animal; Glyburide; He | 2004 |
Activation of mitochondrial ATP-sensitive potassium channels improves rotenone-related motor and neurochemical alterations in rats.
Topics: Animals; Antiparkinson Agents; Basal Ganglia; Catalepsy; Decanoic Acids; Diazoxide; Disease Models, | 2006 |
MitoKATP-channel opener protects against neuronal death in rat venous ischemia.
Topics: Analysis of Variance; Animals; Anti-Arrhythmia Agents; Brain Edema; Brain Infarction; Cell Death; Ce | 2005 |
The cardioprotective effect of isosteviol on rats with heart ischemia-reperfusion injury.
Topics: Animals; Anti-Arrhythmia Agents; Cardiotonic Agents; Decanoic Acids; Disease Models, Animal; Diterpe | 2007 |
Systemic administration of diazoxide induces delayed preconditioning against transient focal cerebral ischemia in rats.
Topics: Analysis of Variance; Animals; Anti-Arrhythmia Agents; Cerebral Infarction; Decanoic Acids; Diazoxid | 2007 |
Hyperoxia confers myocardial protection in mechanically ventilated rats through the generation of free radicals and opening of mitochondrial ATP-sensitive potassium channels.
Topics: Acetylcysteine; Animals; Blood Pressure; Coronary Circulation; Decanoic Acids; Disease Models, Anima | 2008 |
Preconditioning by isoflurane retains its protection against ischemia-reperfusion injury in postinfarct remodeled rat hearts.
Topics: Anesthetics, Inhalation; Animals; Cardiotonic Agents; Chromones; Coronary Vessels; Decanoic Acids; D | 2008 |
Sevoflurane enhances ethanol-induced cardiac preconditioning through modulation of protein kinase C, mitochondrial KATP channels, and nitric oxide synthase, in guinea pig hearts.
Topics: Anesthetics, Inhalation; Animals; Benzophenanthridines; Blotting, Western; Cardiotonic Agents; Decan | 2008 |
KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
Topics: Animals; Aorta; Benzopyrans; Cardiotonic Agents; Decanoic Acids; Disease Models, Animal; Dose-Respon | 2008 |
Antifibrillatory effects of clofilium in the rabbit isolated heart.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Decanoic Acids; Disease Models, Animal; Glyburid | 1994 |
Blockade of ATP-sensitive potassium channels by 5-hydroxydecanoate suppresses monophasic action potential shortening during regional myocardial ischemia.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bl | 1994 |
The ATP-dependent potassium channel: an endogenous cardioprotective mechanism.
Topics: Acetylcholine; Adenosine; Animals; Anti-Arrhythmia Agents; Coronary Disease; Decanoic Acids; Disease | 1994 |
Endothelin-1-induced reduction of myocardial infarct size by activation of ATP-sensitive potassium channels in a rabbit model of myocardial ischaemia and reperfusion.
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Arterial Occlusive Diseases; Blood Pressure | 1995 |